Nontuberculous mycobacterial lung disease in southern Taiwan

Chang Gung Medical Journal

Volumn 32, Issue 5, 2009, Pages 499-508

  Wang, Chin Chou ^a   Lin, Meng Chih ^a   Liu, Jien Wei ^a   Wang, Yi Hsi ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Lung disease; Mycobacterium abscessus; Mycobacterium tuberculosis (MTB); Nontuberculous mycobacterium (NTM); Southern Taiwan

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GENDER; HOSPITAL; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SPECIES; TAIWAN; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; TAIWAN;

EID: 70449360745     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respi Dis 1968;97:1032-1037
2. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006;100:610-615 (Pubitemid 43285747)
3. Gruft H, Falkinham JO III, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981;3:990-996
4. Joos L, Chhajed PN, Wallner J, Battegay M, Steiger J, Gratwohl A, Tamm M. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007;101:93-97 (Pubitemid 44835237)
5. O'brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-1014
6. Henry MT, Inamdar L, O'Riordain D, Schweiger M, Watson JP. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004;23:741-746 (Pubitemid 38618146)
7. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis 2000;31:958-967
8. Henriques B, Hoffner SE, Petrini B, Juhlin I, Wåhlén P, Källenius G. Infection with Mycobacterium malmoense in Sweden: report of 221 Cases. Clin Infect Dis 1994;18:596-600.
9. British Thoracic Society. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment. Eur Respir J 2003;21:478-482
10. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria in cystic fibrosis study group: Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834
11. Doucette K, Fishman JA. Non-tuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004;38:1428-1439 (Pubitemid 38678611)
12. Watanabe K, Fujimura M, Kasahara K, Yasui M, Myou S, Watanabe A, Nakao S. Characteristics of pulmonary Mycobacterium avium-intracellulare complex (MAC) infection in comparison with those of tuberculosis. Respir Med 2003;97:654-659
13. Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med 2002;23:553-567
14. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
15. The Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210-218
16. Ding LW, Lai CC, Lee LN, Hsueh PR. Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect 2006;22:1-8.
17. Shih JY, Hsueh PR, Lee LN, Wang HC, Yang PC, Kuo SH, Luh KT. Nontubeculous mycobacteria isolates: clinical significance and disease spectrum. J Formos Med Assoc 1997;96:621-627
18. Centers for Disease Control, Republic of China (Taiwan). 2004. Department of health, The Executive Tuan, Taiwan. (Available at http://www.cdc.gov.tw)
19. Matos ED, Santana MA, de Santana MC, Mamede P, de Lira Bezerra B, Panão ED, Filho CS, Lemos AC. Nontuberculosis mycobacteria at a multiresistant Tuberculosis reference center in Bahia: clinical epidemiological aspects. Braz J Infect Dis 2004;8:296-304.
20. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:128-133
21. Debrunner M, Salfinger M, Brandli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992;15:330-345
22. Engel HW, Berwald LG, Lindeboom BW, Havelaar AH. Mycobacterium kansasii infections in the Netherlands: a brief summary. Rev Infect Dis 1981;3:1024.
23. Kaustová J, Chmelík M, Ettlová D, Hudec V, Lazarová H, Richtrová S. Disease due to Mycobacterium kansasii in the Czech Republic: 1984-1989. Tuber Lung Dis 1995;76:205-209
24. Pang SC. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med 1991;85:213-218
25. Bollert FG, Watt B, Greening AP, Crompton GK. Nontubetculous pulmonary infections in Scotland: a cluster in Lothian? Thorax 1995;50:188-190
26. Jenkins PA. The epidemiology of opportunist mycobacterial infections in Wales, 1952-1978. Rev Infect Dis 1981;3:1021-1023
27. Corbett EL, Hay M, Churchyard GJ, Herselman P, Clayton T, Williams BG, Hayes R, Mulder D, De Cock KM. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 1999;3:501-507
28. Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM. Non-tuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21. (Pubitemid 29326062)
29. Hosker HS, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
30. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125:388-391
31. Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB, Raz M, Shlomi D, Daniele B, Kramer MR. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest 2006;129:771-776
32. Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 1969;99:73-85.
33. Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Hurst GA. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR Am J Roentgenol 1978;131:985-993
34. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-1278